Increased plasma amyloid β protein 1–42 levels in Down syndrome
- 23 January 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 241 (1), 13-16
- https://doi.org/10.1016/s0304-3940(97)00966-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Amyloid β protein in plasma from patients with sporadic Alzheimer's diseaseJournal of the Neurological Sciences, 1996
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Neuropathology in the Down's syndrome brainNature Medicine, 1996
- Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down SyndromeAnnals of Neurology, 1995
- Amyloid β Protein (Aβ) in Alzheimeri's Disease BrainJournal of Biological Chemistry, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Normal and Abnormal Biology of the beta-Amyloid Precursor ProteinAnnual Review of Neuroscience, 1994
- Down SyndromePediatric Clinics of North America, 1993
- Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's DiseaseNew England Journal of Medicine, 1989
- Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer LocusScience, 1987